Eupraxia Pharmaceuticals Inc. ( EPRX) - Stock Earnings
EPRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
EPRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -16.7 million USD | — USD |
| 2026Q1 | -12.7 million USD | — USD |
| 2026Q2 | -14.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EPRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.2 million USD | — USD |
| 2024 | -25.5 million USD | — USD |
| 2025 | -53.9 million USD | — USD |
| 2026 Est. | — | — |
EPRX
Price: $6.62
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 259.3 million